GSE148200 0 V 5 GEMCITABINE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE148200 0 V 5 GEMCITABINE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE148200 0 V 5 GEMCITABINE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE148200 0 V 5 GEMCITABINE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE148200 0 V 5 GEMCITABINE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

H3 clustered histone 7

Gene

H2A clustered histone 19

Gene

H3.7 histone (putative)

Gene

H2A clustered histone 4

Gene

interleukin 3 receptor subunit alpha

Gene

zinc finger protein 311

Gene

lymphocyte antigen 6 family member G5C

Gene

olfactory receptor family 14 subfamily J member 1

  • Gene

    H4 clustered histone 15


  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    H3 clustered histone 7


  • Gene

    H2A clustered histone 19


  • Gene

    H3.7 histone (putative)


  • Gene

    H2A clustered histone 4


  • Gene

    interleukin 3 receptor subunit alpha


  • Gene

    zinc finger protein 311


  • Gene

    lymphocyte antigen 6 family member G5C


  • Gene

    olfactory receptor family 14 subfamily J member 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.